From the publishers of The New England Journal of Medicine
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.
Some content may require paid access to the site. Subscribe or
purchase a seven-day site pass for the full text of
all our clinical perspectives on medical journal articles, guidelines, and news.
On April 29, the FDA approved the use of once-daily Kaletra (lopinavir/ritonavir) 800 mg/200 mg for the treatment of HIV infection in therapy-naive adult patients. . . .
The HIV Medical Association has provided an up-to-date review on the epidemiology of — and clinical approach to — renal disease in HIV-infected patients. Included . . .
HIV treatment guidelines from DHHS/IDSA were recently updated to include the following:
In March, the AIDS Vaccine Advocacy Coalition released a report on issues surrounding clinical testing of tenofovir for pre-exposure prophylaxis. Some of the trials of . . .
During a recent 5-year period, the overall mortality rate in South Africa increased by 57%, from approximately 318,000 deaths in 1997 to 499,000 in 2002. . . .